Das Bergbauunternehmen ist seit Februar 2020 nicht mehr an einer Börse gelistet. Das Delisting von U.S. Lithium Corp. fand aufgrund einer Umstrukturierung statt.
Ältere Artikel von und über die Gesellschaft befinden (sofern vorhanden) sich im Archiv.
US Lithium Corp. is pleased to announce that its CBD business has launched its beta ecommerce website, www.bioelife.net. The new site will allow wholesale customers, as well as consumers, to register, view and purchase all of BioELife’s current product offerings. This includes adult CBD gum drops, the Company’s highly concentrated [...]
US Lithium Corp. is pleased to announce that it has completed production and began shipping its latest pain cream, ChiroRub 2000. The proprietary formulation, containing 2,000 mg of CBD, has been doctor and patient tested and is one of the most effective pain relief creams currently available on the market today. ChiroRub 2000 was developed in [...]
US Lithium Corp. is pleased to announce that its Board of Directors and shareholders have approved an amendment to the Articles of Incorporation changing the name of the corporation from U.S. Lithium Corp. to BioELife Corp. The name change will better reflect the Company’s new strategic focus on the rapidly growing CBD market. The Company [...]
US Lithium Corp. is pleased to announce that its CBD manufacturing business has been awarded an exclusive purchase and distribution agreement by International Healthcare Network for at least four of its products. One much anticipated product is a highly concentrated topical pain cream developed in conjunction with leading chiropractors across the [...]
US Lithium Corp. is pleased to announce that, effective January 20, 2020, it has acquired four cannabinoid related contracts between Hemp Cloud 9 and four unrelated parties in exchange for 4.7M shares of LITH stock. As a result of these acquisitions the Company will change its primary business from minerals to cannabinoids. The Company also intends [...]
